Basit öğe kaydını göster

Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study

dc.contributor.authorChung, Byung Ha
dc.contributor.authorPereira de Santana Gomes, Andrea J.
dc.contributor.authorLopez-Gitlitz, Angela
dc.contributor.authorMiladinovic, Branko
dc.contributor.authorBasch, Ethan
dc.contributor.authorGiven, Robert
dc.contributor.authorYe, Dingwei
dc.contributor.authorUemura, Hirotsugu
dc.contributor.authorMerseburger, Axel S.
dc.contributor.authorJuarez Soto, Alvaro
dc.contributor.authorÖZGÜROĞLU, Mustafa
dc.contributor.authorChi, Kim N.
dc.contributor.authorAgarwal, Neeraj
dc.contributor.authorMcQuarrie, Kelly
dc.contributor.authorBjartell, Anders
dc.contributor.authorChowdhury, Simon
dc.date.accessioned2021-12-10T09:58:34Z
dc.date.available2021-12-10T09:58:34Z
dc.date.issued2021
dc.identifier.citationAgarwal N., McQuarrie K., Bjartell A., Chowdhury S., Pereira de Santana Gomes A. J. , Chung B. H. , ÖZGÜROĞLU M., Juarez Soto A., Merseburger A. S. , Uemura H., et al., "Apalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study", JOURNAL OF UROLOGY, cilt.206, sa.4, ss.914-922, 2021
dc.identifier.issn0022-5347
dc.identifier.otherav_200eaf06-5661-4279-81ea-cc55de542085
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/168911
dc.identifier.urihttps://doi.org/10.1097/ju.0000000000001841
dc.description.abstractPurpose: We performed an exploratory analysis of prostate cancer-related pain and fatigue on health-related quality of life in patients with metastatic castration-sensitive prostate cancer receiving apalutamide (240 mg/day) or placebo, with continuous androgen deprivation therapy (ADT), in the phase 3, randomized, double-blind, placebo controlled TITAN trial (NCT02489318).
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectNefroloji
dc.subjectNephrology
dc.subjectUrology
dc.subjectHealth Sciences
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.titleApalutamide plus Androgen Deprivation Therapy for Metastatic Castration-Sensitive Prostate Cancer: Analysis of Pain and Fatigue in the Phase 3 TITAN Study
dc.typeMakale
dc.relation.journalJOURNAL OF UROLOGY
dc.contributor.departmentUniversity Of Utah , ,
dc.identifier.volume206
dc.identifier.issue4
dc.identifier.startpage914
dc.identifier.endpage922
dc.contributor.firstauthorID2770357


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster